Proteases—From Basic Structure to Function to Drug Design as Targeted Therapy

In the two last decades, proteases have constituted one of the primary and important targets in drug discovery. The U.S. FDA has approved more than 12 protease therapies in the last 10 years, and a number of next-generation or completely new proteases are under clinical development. Protease inhibit...

Πλήρης περιγραφή